Characterisation of surface-modified solid lipid nanoparticles (SLN):: Influence of lecithin and nonionic emulsifier

被引:242
作者
Schubert, MA [1 ]
Müller-Goymann, CC [1 ]
机构
[1] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Technol, D-38106 Braunschweig, Germany
关键词
haemolysis; neutral red test; physicochemical characterisation; protein adsorption; solid lipid nanoparticles; surface modification;
D O I
10.1016/j.ejpb.2005.03.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solid lipid nanoparticles (SLN), an alternative colloidal drug delivery system to polymer nanoparticles, emulsions and liposomes, are generally produced by high pressure melt-emulsification. However, the harsh production process is not applicable for formulations containing shear and temperature sensitive compounds. For that reason, subsequent adsorptive SLN loading might be a promising alternative. The aim of the present study was the development and characterisation of surface-modified SLN for adsorptive protein loading by variation of both the lipid matrix and the emulsifier concentration in the continuous phase. Variations in SLN composition resulted in particle sizes between 674 and 61 nm corresponding to specific surfaces of 4.5 m(2)/g and 48.9 m(2)/g and zeta potentials between -23.4 mV and -0.9 mV. In dependence of SLN surface properties, albumin payload ranged from 2.5 to 15%. Thermoanalysis, X-ray diffraction and electron microscopy revealed anisometrical and crystalline particles. In vitro cytotoxicity was low in terms of both haemolysis, which was between I and 2%, and neutral red test (NRT) showing a half lethal dose between 1.1 and 4.6%. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 30 条
[1]   Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters [J].
Almeida, AJ ;
Runge, S ;
Muller, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 149 (02) :255-265
[2]   Influence of n-octenylsuccinate starch on in vitro permeation of sodium diclofenac across excised porcine cornea in comparison to Voltaren ophtha [J].
Baydoun, L ;
Müller-Goymann, CC .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (01) :73-79
[3]   Crystallization tendency and polymorphic transitions in triglyceride nanoparticles [J].
Bunjes, H ;
Westesen, K ;
Koch, MHJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 129 (1-2) :159-173
[4]  
Cavalli R, 1999, STP PHARMA SCI, V9, P183
[5]   SOLID LIPOSPHERES OF DOXORUBICIN AND IDARUBICIN [J].
CAVALLI, R ;
CAPUTO, O ;
GASCO, MR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 89 (01) :R9-R12
[6]   PREPARATION AND STRUCTURE OF A WATER-IN-OIL CREAM CONTAINING LIPID NANOPARTICLES [J].
DEVRINGER, T ;
DERONDE, HAG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :466-472
[7]   Characterization of solidified reverse micellar solutions (SRMS) and production development of SRMS-based nanosuspensions [J].
Friedrich, I ;
Müller-Goymann, CC .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (01) :111-119
[8]   Plasma protein adsorption of Tween 80-and poloxamer 188-stabilized solid lipid nanoparticles [J].
Göppert, TM ;
Müller, RH .
JOURNAL OF DRUG TARGETING, 2003, 11 (04) :225-231
[9]  
Hagemann J., 1988, CRYSTALLIZATION POLY, P29
[10]   Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride [J].
Heiati, H ;
Phillips, NC ;
Tawashi, R .
PHARMACEUTICAL RESEARCH, 1996, 13 (09) :1406-1410